See also this year's filing and all EDGAR filings for this company.
PDF Report 0001701108_2018_Spero_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001701108')"} |
Graph
Absolute values for 0001701108, Spero Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 92,059,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,164,000 |
| 3 | remainder_Assets | 256,000 |
| 4 | LiabilitiesCurrent | 8,157,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 365,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,840,000 |
| 9 | ResearchAndDevelopmentExpense | 32,869,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,823,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 93,479,000 |
| 1 | Liabilities | 8,522,000 |
| 2 | Expenses | 43,709,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 84,957,000 |
| 5 | NetIncome | -39,886,000 |
| 6 | ComprehensiveNetIncome | -39,886,000 |
| 7 | BaseVar | 74,766,500 |
| 8 | EconomicCapitalRatio | 2.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
